バージニアマイシンの2030年までの市場予測：タイプ別、動物別、流通チャネル別、用途別、地域別の世界分析

Stratistics MRCによると、世界のバージニアマイシン市場は2023年に1億8,505万米ドルを占め、予測期間中に7.5％のCAGRで成長し、2030年までに3億701万米ドルに達すると予想されています。

バージニアマイシンは、成長を後押しし、細菌感染から守るために家畜や養鶏の飼料添加物としても使用されている強力な抗生物質です。バージニアマイシン M1とバージニアマイシン S1という2つの近縁成分が、ストレプトグラミン・グループの一員であるこの抗生物質を構成しています。さらに、これらの要素は、細胞内のタンパク質合成を防止することにより、細菌の増殖を抑制します。グラム陽性菌に対するその卓越した効能により、ヴィルジニアマイシンは疾病予防や動物の健康増進のための貴重なツールとなっています。

米国獣医師会（AVMA）によると、バージニアマイシンのような化合物を含む抗生物質の責任ある使用は、農業環境における動物の健康と幸福を確保する上で非常に重要です。

家畜生産の増加

世界の畜産物のための成長の需要はバージニアマイシンの市場を運転する主要な要因の1つです。肉や乳製品の需要増に対応するため、世界の人口が増え続ける中、効率的で持続可能な畜産がますます重要になってきています。さらに、バージニアマイシンは、家畜の感染症を予防し、成長を促進するのに役立つため、集約的な畜産の実践を支持する大きな要因となっています。

抗生物質耐性への懸念

抗生物質耐性に関する懸念の高まりは、バージニアマイシン市場に影響を与える主な要因の一つです。ヴィルジニアマイシンのような抗生物質を家畜に広く継続的に使用していることが、耐性菌の出現の要因になっている可能性があります。さらに、耐性菌が食物連鎖を介して人に広がる可能性があるため、家畜だけでなく公衆衛生も危険にさらされます。また、抗生物質の長期的な有効性も低下します。

正確な畜産への使用拡大

バージニアマイシンの市場は、自動化、データ分析、センサー技術の発展に後押しされた精密畜産の利用拡大から恩恵を受けると予想されます。さらに、バージニアマイシンやその他の飼料添加物は、成長と健康の成果を最大化するために正確に適用することができます。精密農業は、動物の健康パラメータと飼料効率をより正確に監視することを可能にします。

高まる規制の抑制

畜産における抗生物質の使用に対する規制の監視の高まりと規制強化は、バージニアマイシン市場に深刻な脅威をもたらします。抗生物質耐性への懸念から、政府や国際機関により厳しい規制が敷かれつつあり、バージニアマイシンの供給や使用が制限される可能性があります。さらに、市場参入企業は変化する規制基準を遵守するという課題に直面しています。

COVID-19の影響：

サプライチェーンの混乱、労働力不足、農業・畜産業界全体に影響を与えた経済の不確実性により、COVID-19の大流行はバージニアマイシン市場に大きな影響を及ぼしています。パンデミックによってもたらされた閉鎖や制限は、バージニアマイシンのような飼料添加物の製造や流通を妨げる物流上の困難をもたらしました。さらに、一部の畜牛生産者は経済的打撃の結果、支出を見直したため、これらの添加物市場に影響を与える可能性があります。

予測期間中、家禽セグメントが最大になる見込み

バージニアマイシン市場では、養鶏が最大のシェアを占めています。鶏やその他の家禽種の成長を促し、細菌感染から守るため、養鶏業界は飼料添加物としてバージニアマイシンをふんだんに使用しています。効果的で持続可能な養鶏の必要性は、人口増加や食の嗜好の変化により、家禽製品に対する世界の絶え間ない需要の結果として高まっています。さらに、鶏群の健康と生産高を維持するための有用なツールは、グラム陽性菌に対するその効力により、バージニアマイシンです。

牛・家禽用飼料添加物セグメントは予測期間中CAGRが最も高くなると予想されます。

牛・家禽用飼料添加物は、CAGRが最も高いバージニアマイシン市場セグメントです。食肉・家禽製品の需要の高まりと持続可能な動物生産方法の必要性により、この市場は大きく拡大しています。抗生物質飼料添加物であるバージニアマイシンは、コクシジウム症や壊死性腸炎など、牛や家禽の病気を治療・予防する能力が高く評価されています。さらに、成長を刺激し、飼料転換効果を高め、体重増加を促し、動物の全般的な健康状態を改善します。

最大のシェアを持つ地域：

バージニアマイシン市場で最も大きなシェアを占めているのは北米であろう。北米は畜産業が発達しており、肉や鶏肉製品の需要が高いため、バージニアマイシンの主要な消費者です。牛や家禽の飼料添加物としてのバージニアマイシンの採用は、同地域の食品安全や動物の健康に関する厳しい規制にも影響されています。さらに、持続可能な動物生産方法の推進も北米の主要な優先事項であり、同地域のバージニアマイシン市場の拡大を支えています。

CAGRが最も高い地域：

アジア太平洋地域は、バージニアマイシン市場で最も高いCAGRを持っていると予想されます。アジア太平洋地域では、牛や家禽の飼料添加物としてのバージニアマイシンの需要が大幅に上昇しています。人口の増加、可処分所得の増加、食生活の嗜好の変化により、肉や家禽製品の消費量が増加していることが、この成長の主な要因です。さらに、この地域では、より集約的な畜産方法への移行が見られるため、感染症を予防し成長を促進するためにバージニアマイシンのような抗生物質の適用が必要とされています。

無料のカスタマイズ提供：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のバージニアマイシン市場：タイプ別

• 家禽
• 水産養殖
• その他のタイプ

第6章 世界のバージニアマイシン市場：動物別

• コンパニオンアニマル
• 牛
• 豚
• その他動物

第7章 世界のバージニアマイシン市場：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界のバージニアマイシン市場：用途別

• 壊死性腸炎
• コクシジウム症
• 成長刺激
• 牛および家禽用飼料添加物
• その他の用途

第9章 世界のバージニアマイシン市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Elanco
• Merck Animal Health
• Ceva
• Merial
• Bayer Animal Health
• Phibro Animal Health Corporation
• Vetoquinol
• Boehringer Ingelheim
• Virbac
• Zoetis

List of Tables

• Table 1 Global Virginiamycin Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 4 Global Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 5 Global Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 6 Global Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 7 Global Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 8 Global Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 9 Global Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 10 Global Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 11 Global Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 12 Global Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 13 Global Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 14 Global Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 15 Global Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 16 Global Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 17 Global Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 18 Global Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 19 Global Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 20 Global Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 21 North America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 23 North America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 24 North America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 25 North America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 26 North America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 27 North America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 28 North America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 29 North America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 30 North America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 31 North America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 32 North America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 33 North America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 34 North America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 35 North America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 36 North America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 37 North America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 38 North America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 39 North America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 40 North America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 41 Europe Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 43 Europe Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 44 Europe Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 45 Europe Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 46 Europe Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 47 Europe Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 48 Europe Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 49 Europe Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 50 Europe Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 51 Europe Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 52 Europe Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 53 Europe Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 54 Europe Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 55 Europe Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 56 Europe Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 57 Europe Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 58 Europe Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 59 Europe Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 60 Europe Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 Asia Pacific Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 63 Asia Pacific Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 64 Asia Pacific Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 65 Asia Pacific Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 66 Asia Pacific Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 67 Asia Pacific Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 68 Asia Pacific Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 69 Asia Pacific Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 70 Asia Pacific Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 71 Asia Pacific Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 72 Asia Pacific Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 73 Asia Pacific Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 74 Asia Pacific Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 75 Asia Pacific Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 76 Asia Pacific Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 77 Asia Pacific Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 78 Asia Pacific Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 79 Asia Pacific Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 80 Asia Pacific Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 81 South America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 83 South America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 84 South America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 85 South America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 86 South America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 87 South America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 88 South America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 89 South America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 90 South America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 91 South America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 92 South America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 93 South America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 94 South America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 95 South America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 96 South America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 97 South America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 98 South America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 99 South America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 100 South America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 101 Middle East & Africa Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
• Table 103 Middle East & Africa Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
• Table 104 Middle East & Africa Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
• Table 105 Middle East & Africa Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
• Table 106 Middle East & Africa Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
• Table 107 Middle East & Africa Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
• Table 108 Middle East & Africa Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
• Table 109 Middle East & Africa Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
• Table 110 Middle East & Africa Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
• Table 111 Middle East & Africa Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 112 Middle East & Africa Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
• Table 113 Middle East & Africa Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 114 Middle East & Africa Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 115 Middle East & Africa Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
• Table 116 Middle East & Africa Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
• Table 117 Middle East & Africa Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
• Table 118 Middle East & Africa Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
• Table 119 Middle East & Africa Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
• Table 120 Middle East & Africa Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Virginiamycin Market is accounted for $185.05 million in 2023 and is expected to reach $307.01 million by 2030 growing at a CAGR of 7.5% during the forecast period. Virginiamycin is a strong antibiotic that is also used as a feed additive in livestock and poultry farming to boost growth and guard against bacterial infections. Virginiamycin M1 and Virginiamycin S1, its two closely related components, make up this antibiotic that is a member of the streptogramin group. Additionally, these elements suppress bacterial growth by preventing protein synthesis in the cells. Due to its exceptional efficacy against Gram-positive bacteria, Virginiamycin is a valuable tool for disease prevention and enhancing animal health in general.

According to the American Veterinary Medical Association (AVMA), the responsible use of antibiotics, including compounds such as Virginiamycin, is crucial in ensuring the health and well-being of animals in agricultural settings.

Market Dynamics:

Driver:

Increasing production of livestock

The growing demand for livestock products worldwide is one of the major factors driving the Virginiamycin market. To meet the rising demand for meat and dairy products, efficient and sustainable livestock production is becoming more and more important as the world's population continues to rise. Moreover, virginiamycin is a major factor in favor of intensive animal farming practices because it helps to prevent infections and promote growth in livestock.

Restraint:

Antibiotic resistance concerns

The increasing worry about antibiotic resistance is one of the major factors affecting the Virginiamycin market. The widespread and ongoing use of antibiotics, such as Virginiamycin, in cattle may be a factor in the emergence of bacterial strains that are resistant. Furthermore, due to the fact that resistant bacteria may spread to humans via the food chain, this puts public health at risk in addition to that of animals. It also reduces the antibiotics' long-term efficacy.

Opportunity:

Growing use of accurate livestock production

The market for virginiamycin is expected to benefit from the increasing use of precision livestock farming, which is being fueled by developments in automation, data analytics, and sensor technologies. Moreover, virginiamycin and other feed additives can be applied precisely to maximize growth and health outcomes. Precision farming makes it possible to monitor animal health parameters and feed efficiency more precisely.

Threat:

Growing restraints on regulations

The increasing regulatory scrutiny and tightening restrictions on the use of antibiotics in livestock farming pose a serious threat to the Virginiamycin market. Stricter regulations are being put in place by governments and international organizations in response to worries about antibiotic resistance, which may restrict the supply and use of Virginiamycin. Furthermore, market participants face challenges in adhering to changing regulatory standards.

Covid-19 Impact:

Due to supply chain disruptions, labor shortages, and economic uncertainties that have impacted the entire agriculture and livestock industry, the COVID-19 pandemic has had a significant impact on the Virginiamycin market. Lockdowns and restrictions brought on by the pandemic created logistical difficulties that hampered the manufacture and distribution of feed additives, such as Virginiamycin. Moreover, some cattle producers have reevaluated their expenditures as a result of the economic fallout, which could affect the market for these additives.

The Poultry segment is expected to be the largest during the forecast period

In the market for Virginiamycin, poultry farming has the largest share. To encourage growth and guard against bacterial infections in hens and other poultry species, the poultry industry uses Virginiamycin as a feed additive liberally. The need for effective and sustainable poultry farming practices has grown as a result of the world's constant demand for poultry products, which is being driven by population growth and shifting food preferences. Additionally, a useful tool for preserving the wellbeing and output of chicken flocks is Virginiamycin, due to its potency against Gram-positive bacteria.

The Feed Additive for Cattle and Poultry segment is expected to have the highest CAGR during the forecast period

Feed Additive for Cattle and Poultry is the Virginiamycin market segment with the highest CAGR. Due to the rising demand for meat and poultry products as well as the necessity of using sustainable animal production methods, this market is expanding significantly. The antibiotic feed additive virginiamycin is highly prized for its ability to treat and prevent diseases in cattle and poultry, including coccidiosis and necrotic enteritis. Furthermore, it also stimulates growth, increasing feed conversion effectiveness, encouraging weight gain, and improving the general health of the animal.

Region with largest share:

North America is probably the region with the largest share of the Virginiamycin market. Because of its well-established livestock industry and strong demand for meat and poultry products, North America is a major consumer of Virginiamycin. The adoption of Virginiamycin as a feed additive for cattle and poultry is also influenced by the region's strict regulations regarding food safety and animal health. Moreover, the promotion of sustainable animal production methods is another major priority in North America, which supports the expansion of the Virginiamycin market there.

Region with highest CAGR:

The Asia-Pacific region is anticipated to have the highest CAGR in the Virginiamycin market. The demand for Virginiamycin as a feed additive for cattle and poultry is rising significantly in the Asia-Pacific area. The growing population, rising disposable income, and shifting dietary preferences-which result in a greater consumption of meat and poultry products-are the main drivers of this growth. Furthermore, the area is witnessing a transition towards more intensive methods of animal husbandry, thereby requiring the application of antibiotics such as Virginiamycin to prevent infections and enhance growth.

Key players in the market

Some of the key players in Virginiamycin market include Elanco, Merck Animal Health, Ceva, Merial, Bayer Animal Health, Phibro Animal Health Corporation, Vetoquinol, Boehringer Ingelheim, Virbac and Zoetis.

Key Developments:

In November 2023, CEVA Logistics completed its acquisition of Stellar Value Chain. CEVA acquired a 96% stake in the Mumbai-based warehousing and transportation specialists from an affiliate of private equity form Warburg Pincus and other shareholders. The acquisition adds to CEVA's existing presence in India, allowing for the delivery of holistic supply chain services to customers across the Asia Pacific region and beyond.

In August 2023, Merck Animal Health announced Dec. 6 that it has acquired Prondil S.A., a privately held company specializing in the development and manufacturing of animal health vaccines for livestock. Specific terms of the agreement were not disclosed. Prondil, located in Montevideo, Uruguay, is an internationally recognized supplier of antigens and vaccines for veterinary use. The company's wide range of products is sold in more than 20 countries.

In May 2023, Elanco Animal Health Incorporated has entered into an agreement with Aptimmune Biologics, Inc., as the exclusive distributor of their porcine reproductive and respiratory syndrome inactivated, or killed, vaccine based on Aptimmune's Barricade technology platform in the United States. An inactivated vaccine is one consisting of virus particles, bacteria or other pathogens that have been grown in culture and then killed to destroy disease-producing capacity.

Types Covered:

• Poultry
• Aquaculture
• Other Types

Animals Covered:

• Companion Animals
• Cattle
• Swine
• Other Animals

Distribution Channels Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Applications Covered:

• Necrotic enteritis
• Coccidiosis
• Growth Stimulation
• Feed Additive for Cattle and Poultry
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• sAsia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Virginiamycin Market, By Type

• 5.1 Introduction
• 5.2 Poultry
• 5.3 Aquaculture
• 5.4 Other Types

6 Global Virginiamycin Market, By Animal

• 6.1 Introduction
• 6.2 Companion Animals
• 6.3 Cattle
• 6.4 Swine
• 6.5 Other Animals

7 Global Virginiamycin Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Hospital Pharmacies
• 7.3 Retail Pharmacies
• 7.4 Online Pharmacies

8 Global Virginiamycin Market, By Application

• 8.1 Introduction
• 8.2 Necrotic enteritis
• 8.3 Coccidiosis
• 8.4 Growth Stimulation
• 8.5 Feed Additive for Cattle and Poultry
• 8.6 Other Applications

9 Global Virginiamycin Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Elanco
• 11.2 Merck Animal Health
• 11.3 Ceva
• 11.4 Merial
• 11.5 Bayer Animal Health
• 11.6 Phibro Animal Health Corporation
• 11.7 Vetoquinol
• 11.8 Boehringer Ingelheim
• 11.9 Virbac
• 11.10 Zoetis